News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
248 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (258)
2 (248)
3 (119)
4 (1)
5 (30)
6 (211)
7 (196)
8 (187)
9 (224)
10 (123)
11 (42)
12 (30)
13 (282)
14 (254)
15 (234)
16 (227)
17 (162)
18 (1)
19 (7)
20 (203)
21 (157)
22 (183)
23 (103)
24 (13)
25 (1)
27 (71)
28 (66)
29 (85)
30 (85)
31 (20)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
27
28
29
30
31
Policy
BeiGene and EUSA Pharma Announce NMPA Approval of SYLVANT® (Siltuximab for Injection) in China for Idiopathic Multicentric Castleman Disease
BeiGene, Ltd. and EUSA Pharma, Ltd. announced that the China National Medical Products Administration has approved SYLVANT® for the treatment of adult patients with multicentric Castleman disease who are human immunodeficiency virus negative and human herpes virus-8 negative, also known as idiopathic MCD.
December 2, 2021
·
8 min read
Policy
BeiGene Announces Inclusion in the China National Reimbursement Drug List (NRDL) of Tislelizumab in Three New Indications, BRUKINSA® (Zanubrutinib) in One New Indication, and the First Listing for Pamiparib
BeiGene, a global science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, announced that three of its medicines have been added to the most recent National Reimbursement Drug List in China by the National Healthcare Security Administration.
December 2, 2021
·
12 min read
Wound Irrigation Systems Market: Manual Wound Irrigation Systems to Witness Significant Demand
Wound irrigation is the steady flow of a solution across an open wound surface to remove deeper debris, achieve wound hydration, and assist with the visual examination.
December 2, 2021
·
6 min read
Veterinary Reference Laboratories Market: Strategies Adopted by Key Players to Offer Attractive Opportunities to Market
Veterinary reference laboratories are the laboratories wherein various key functions associated with veterinary science, including determination of treatment options, diagnosis, prevention, and monitoring of animal diseases take place.
December 2, 2021
·
6 min read
Policy
Innovent and Lilly Announce Successful Expansion of Sintilimab in China National Reimbursement Drug List to Include Three Additional First-Line Indications
Innovent Biologics, Inc. and Eli Lilly and Company, announce that the innovative PD-1 inhibitor sintilimab has been successfully included in the updated National Reimbursement Drug List for all approved indications, according to the latest announcement from the China National Healthcare Security Administration.
December 2, 2021
·
11 min read
Surgical Scalpel Market Study | Recent Innovations and Technological Advancements Analysis
The global surgical scalpel market is expected to witness a significant growth in the next few years. The increasing number of surgical procedures and innovations in the healthcare industry are projected to enhance the growth of the overall market in the near future.
December 2, 2021
·
4 min read
Rare Disease Treatment Market | Current Insight with Future Aspect Analysis
The healthcare industry is moving with a massive pace towards transformation. With implementation of new technologies and innovative devices the industry is redefining the treatments from inside out.
December 2, 2021
·
6 min read
Nosocomial Infection Treatment Market: Increase in Incidence of Hospital-acquired Infections is Projected to Boost the Growth of the Market
Nosocomial infection is termed as infection caused within 48 hours of hospital admission. Hence, it is also known as hospital-acquired infection. Patients in intensive care units (ICU) are more prone to hospital-acquired infections.
December 2, 2021
·
5 min read
Pediatric Examination Tables Market: Pediatric Clinics Segment to Offer Significant Opportunities
Pediatric examination tables are portable stretchers or beds used to lay pediatric patients down to examine them. These are installed in pediatric clinics, hospitals, and ambulatory surgery centers for diagnosis of medical conditions and routine checkups.
December 2, 2021
·
6 min read
Extracorporeal Shock Wave Lithotripsy Devices to Account for Major Lithotripsy Devices Market Revenue Share
Fact.MR – A Market Research and Competitive Intelligence Provider: The market for lithotripsy devices is expected to exceed US$ 2 billion by 2031.
December 2, 2021
·
6 min read
Previous
22 of 25
Next